CardiaTec secures $6.5M seed funding to accelerate its mission to combat cardiovascular disease using computational drug discovery. A cardiovascular CardiaTec secures $6.5M seed funding to advance its computational drug discovery platform, using human multi-omics data to combat cardiovascular disease and identify novel therapeutics.
CardiaTec snaps $6.5M seed funding to revolutionise cardiovascular drug discovery
This was originally published on post